GT Biopharma, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-0.11 | $-0.05 |
| FY2022 | $-6.55 | $-0.75 |
| FY2023 | $-1.88 | $-0.94 |
| FY2024 | $-6.94 | $-1.64 |
| FY2025 | $-6.68 | $-2.30 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-0.11 | $-0.05 |
| FY2022 | $-6.55 | $-0.75 |
| FY2023 | $-1.88 | $-0.94 |
| FY2024 | $-6.94 | $-1.64 |
| FY2025 | $-6.68 | $-2.30 |